Drugs / Quadrivalent Live Attenuated Influenza Vaccine
Quadrivalent Live Attenuated Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02474901 Comparator | Jul 2013 → Mar 2016 | HIV infectious disease | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent Live Attenuated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02474901 ↗ |
| Modality | Vaccine | “QLAIV is an intranasal vaccine” NCT02474901 ↗ |
| Route | Intranasal | “QLAIV is an intranasal vaccine” NCT02474901 ↗ |